Editorial Comment on: A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

被引：2
|
作者：
van der Poel, Henk G. [1 ]
机构：
[1] Netherlands Canc Inst, Dept Urol, Amsterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2009年 / 56卷 / 01期
关键词：
D O I：
10.1016/j.eururo.2009.02.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase 1 Study of Testosterone Replacement for Patients With Low-Risk Castration-Resistant Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2729 - 2730
  • [2] A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer
    Szmulewitz, Russell
    Mohile, Supriya
    Posadas, Edwin
    Kunnavakkam, Rangesh
    Karrison, Theodore
    Manchen, Elizabeth
    Stadler, Walter M.
    EUROPEAN UROLOGY, 2009, 56 (01) : 97 - 103
  • [3] Enzalutamide for Patients with castration-resistant Prostate Cancer Comment
    Kretschmer, Alexander
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [4] Antitumour Activity of MDV3100 in Castration-Resistant Prostate Cancer: A Phase 1-2 Study Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 184 (06): : 2330 - 2330
  • [5] Editorial Comment to Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer
    Yamamoto, Yoshiyuki
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (07) : 831 - 832
  • [6] The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer
    Drazer, Michael W.
    Stadler, Walter M.
    CANCER JOURNAL, 2016, 22 (05): : 330 - 333
  • [7] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 897 - 898
  • [8] Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 31 - 31
  • [9] Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Morris, Michael J.
    Huang, Daisy
    Kelly, William K.
    Slovin, Susan F.
    Stephenson, Ryan D.
    Eicher, Caitlin
    Delacruz, Anthony
    Curley, Tracy
    Schwartz, Lawrence H.
    Scher, Howard I.
    EUROPEAN UROLOGY, 2009, 56 (02) : 237 - 244
  • [10] Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
    Winquist, Eric
    Hotte, Sebastien J.
    Chi, Kim
    Sridhar, Srikala
    Ellard, Susan
    Ong, Michael
    Iqbal, Nayyer
    Salim, Muhammad
    Emmenegger, Urban
    Gingerich, Joel R.
    Lalani, Aly-Khan
    Major, Pierre
    Kollmannsberger, Christian
    Yip, Steven
    Hansen, Aaron
    Finch, Daygen
    Canil, Christina
    Hutchenreuther, James
    Vera-Badillo, Francisco
    Smoragiewicz, Martin
    Cabanero, Michael
    Tsao, Ming-Sound
    Ritch, Elie
    Wyatt, Alexander W.
    Seymour, Lesley
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 45 - 55
12345